Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Abatacept, rituximab or tocilizumab[3] Abatacept,
Rituximab,
Tocilizumab		[3] D02596 ,
D02994 (Name: Rituximab),
D03203 		[4] CD80,
CD86,
IL6R,
MS4A1 💬		[24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46
2ABP 798 - Biosimilar to rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
3ABP 798 Biosimilar to Rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
4Administration of rituximab and methylprednisolone[2] Methylprednisolone,
Rituximab		[7] D00407 ,
D00751 ,
D00979 ,
D02994 (Name: Rituximab),
D05000 ,
D05001 ,
D05002 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 51
5Alemtuzumab and Rituximab[2] Alemtuzumab,
Rituximab		[2] D02802 ,
D02994 (Name: Rituximab)		[2] CD52,
MS4A1 💬		[2] , Hematopoietic cell lineage 💬[1] 60
6Alemtuzumab, Rituximab[2] Alemtuzumab,
Rituximab		[2] D02802 ,
D02994 (Name: Rituximab)		[2] CD52,
MS4A1 💬		[2] , Hematopoietic cell lineage 💬[1] 63
7Bendamustine, Rituximab[2] Bendamustine,
Rituximab		[2] D02994 (Name: Rituximab),
D07501 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 61
8Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine[3] Azathioprine,
Dexamethasone,
Rituximab		[12] D00238 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994 (Name: Rituximab),
D03033 		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 35
9Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 85
10Dexamethasone and Rituximab[2] Dexamethasone,
Rituximab		[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D02994 (Name: Rituximab)		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63
11Double-Blind Rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 51
12Dr. Reddy’s Rituximab (DRL_RI) 100mg[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
13Dr. Reddy’s Rituximab (DRL_RI) 500mg[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
14Eltrombopag combining rituximab[2] Eltrombopag,
Rituximab		[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 63
15Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab[4] Abatacept,
Rituximab,
Sarilumab,
Tocilizumab		[4] D02596 ,
D02994 (Name: Rituximab),
D03203 ,
D10161 		[4] CD80,
CD86,
IL6R,
MS4A1 💬		[24] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46
16Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 222
17GP2013 - A Proposed biosimilar rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
18IDEC-C2B8 (rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
19Immunosuppressive treatment (eg, rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 64
20Individualized dose of rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 49
21Intravenous Rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 66
22MabionCD20 (candidate biosimilar to rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
23MabThera (Rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[4] 13, 46, 49, 53
24Mabthera or biosimilar Rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 61
25Mabthera or biosimilar rituximab product[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
26MabThera® (rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
27Originator rituximab - Rituxan ® or MabThera ®[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
28Prednisone, low dose rituximab[2] Prednisone,
Rituximab		[2] D00473 ,
D02994 (Name: Rituximab)		[2] MS4A1,
NR3C1 💬		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 61
29RhTPO in combination with Rituximab[2] Recombinant Human Thrombopoietin,
Rituximab		[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 63
30Rituxan (INN: Rituximab), brand name in the United States[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
31Rituxan (INN: Rituximab), brand name in the US[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
32Rituxan (rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 49
33Rituxan® (rituximab)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
34Rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[49] 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
35Rituximab (anti-CD20)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 53
36Rituximab (Arm A)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 43, 44
37Rituximab (Arm B)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 43, 44
38Rituximab (EU)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
39Rituximab (genetical recombination)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 14
40Rituximab (MABTHERA® or RITUXAN®).[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 35, 61
41Rituximab (Mabthera®)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 61
42Rituximab (Rituxan)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 11
43Rituximab (RTX) and Azathioprine (AZA)[2] Azathioprine,
Rituximab		[3] D00238 ,
D02994 (Name: Rituximab),
D03033 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 65
44Rituximab (US)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
45Rituximab - MabThera[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
46Rituximab 1g IV[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 162
47Rituximab [MabThera/Rituxan][1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 46, 63
48Rituximab [MabThera][1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
49Rituximab and Cyclophosphamide IV[2] Cyclophosphamide,
Rituximab		[3] D00287 ,
D02994 (Name: Rituximab),
D07760 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 35
50Rituximab and Hyaluronidase Human[2] Hyaluronidase,
Rituximab		[4] D02994 (Name: Rituximab),
D04455 ,
D04456 ,
D06604 		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 331
51Rituximab combined with Omalizumab[2] Omalizumab,
Rituximab		[2] D02994 (Name: Rituximab),
D05251 		[2] FCER1A,
MS4A1 💬		[5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 162
52Rituximab Infusion[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[2] 13, 222
53Rituximab IT[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
54Rituximab IV[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
55Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 13
56Rituximab MabThera[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
57Rituximab, Mabthera[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 53
58Rituximab, MTX, folic acid[2] Folic acid,
Rituximab		[2] D00070 ,
D02994 (Name: Rituximab)		[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
59Rituximab, observational study amon patients with active RA[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
60Rituximab-EU+ Rituximab-Pfizer x 2 Courses[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
61Rituximab-Pfizer[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
62Rituximab-Pfizer (PF-05280586) x 3 courses[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
63Rituximab-US + Rituximab-Pfizer x 2 Courses[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
64Rituximab/ Mabthera[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 271
65SAIT101 (proposed rituximab biosimilar)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
66SAIT101 (rituximab biosimilar)[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 46
67Standard dose of rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 49
68The Standard Steroid Treatment, Plasma Exchange and rituximab[1] Rituximab[1] D02994 (Name: Rituximab)[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 85